Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Trump Tariffs: Indian Pharma Dodges Bullet, But Sword May Remain
Question About Costs For Firms With US Manufacturing
Apr 04 2025
•
By
Vibha Ravi
US tariffs are raising economic concerns around the world.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Manufacturing
More from Legislation